New hope for young bone cancer patients: immune drug tested in relapse
NCT ID NCT03006848
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tested a drug called avelumab in 19 children and young adults (ages 12 to 49) whose osteosarcoma (a type of bone cancer) had come back or was not responding to standard treatments. The goal was to see if avelumab could shrink tumors or stop the cancer from growing for at least 16 weeks. Researchers also monitored side effects and quality of life. The drug works by helping the immune system attack cancer cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
-
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065, United States
-
St Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
-
Texas Children's Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.